# Nascent Biotech Inc.

Nascent Biotech Inc. is a company headquartered in North Palm Beach, FL, United States.

## Company overview

- **Legal name:** Nascent Biotech Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** North Palm Beach, FL, United States
- **Incorporated in:** NV
- **Fiscal year end:** March 31
- **SEC CIK:** 0001622057

## About

Nascent Biotech Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001622057, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-07-01, it reported net income of USD -2,087,682; total assets of USD 552,120 for the fiscal period ended 2024-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-03-31)

- **Net income:** -$2.1M (USD -2,087,682)
- **Total assets:** $552,120 (USD 552,120)
- **Operating cash flow:** -$1.2M (USD -1,186,066)

### FY2023 (period ended 2023-03-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$2.8M (USD -2,800,969)
- **Total assets:** $255,002 (USD 255,002)
- **Operating cash flow:** -$1.8M (USD -1,787,228)

### FY2022 (period ended 2022-03-31)

- **Revenue:** $1.0M (USD 1,000,000)
- **Net income:** -$470,390 (USD -470,390)
- **Total assets:** $105,414 (USD 105,414)
- **Operating cash flow:** $413,479 (USD 413,479)

### FY2021 (period ended 2021-03-31)

- **Revenue:** $750,000 (USD 750,000)
- **Net income:** -$958,767 (USD -958,767)
- **Total assets:** $751,435 (USD 751,435)
- **Operating cash flow:** -$986,784 (USD -986,784)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2025-01-17 — period 2025-01-10 — FORM 8-K
- Form 10-Q — filed 2024-08-14 — period 2024-06-30 — FORM 10-Q
- Form 10-K — filed 2024-07-01 — period 2024-03-31 — FORM 10-K
- Form S-1 — filed 2024-03-15 — FORM S-1
- Form 10-Q — filed 2024-02-14 — period 2023-12-31 — FORM 10-Q
- Form 8-K — filed 2023-12-19 — period 2023-12-15 — FORM 8-K
- Form 10-Q — filed 2023-11-09 — period 2023-09-30 — FORM 10-Q
- Form 8-K — filed 2023-09-06 — period 2023-08-31 — FORM 8-K
- Form 10-Q — filed 2023-08-18 — period 2023-06-30 — FORM 10-Q
- Form 8-K — filed 2023-07-14 — period 2023-06-29 — FORM 8-K
- Form 10-K/A — filed 2023-07-03 — period 2023-03-31 — FORM 10-K/A
- Form 10-K — filed 2023-06-29 — period 2023-03-31 — FORM 10-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/nascent-biotech-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology